QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module VII — PSUR Reference Data and International Safety Information

Test your understanding of the concepts covered by GVP Module VII: PSUR Reference Data and International Safety Information.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A country outside the EU shows a large increase in adverse-event reports. Which interpretation is most appropriate initially?

The EU risk has increased by the same proportion The increase is irrelevant because it occurred outside the EU The increase should be evaluated with exposure, reporting behaviour, case characteristics, local use patterns and mechanistic relevance The increase proves that a new EU contraindication is required

Question 2 of 10 A suspected signal is closed without changing the reference safety information. How should this status be reflected in the PSUR?

Present the signal as an established new risk because it was initially suspected Omit the signal because closure has no scientific relevance Describe the evaluation and closure rationale, making clear that the evidence did not support incorporation into established safety information State that closure proves the reaction is unrelated to the product in every case

Question 3 of 10 What is the main inspection concern when a PSUR uses a reference document but cannot show why it was selected?

The document may be too short for a PSUR The organisation lacks evidence that the baseline was appropriate, controlled and traceable to the assessment The document must be replaced by a global core document in all cases The PSUR cannot contain any international safety information

Question 4 of 10 Which data-lineage chain is most appropriate for an international regulatory action considered in a PSUR?

International source, applicability assessment, integration into the EU evidence base, and benefit-risk conclusion International source, automatic EU label change, and deletion of conflicting evidence Foreign authority name, case count, and automatic signal closure Global database entry, exclusion of local context, and final submission

Question 5 of 10 Which governance role is most appropriate for the QPPV regarding reference information in PSURs?

Personally maintain every product-information version for every jurisdiction Ensure that governance and escalation allow material reference changes and international findings to be recognised and reflected appropriately in PSUR conclusions Approve every foreign label change as an EU regulatory decision Delegate all interpretation to the global safety database without oversight

Question 6 of 10 A US authority adds a warning, but the EU SmPC remains unchanged. How should the US action generally be represented in the PSUR?

As proof that the EU product information changed As irrelevant because the EU SmPC was not amended As relevant international safety information requiring assessment of its evidence and applicability to the EU product As an automatic instruction to implement the same warning in the EU

Question 7 of 10 A safety concern is reported with an intravenous formulation, while the MAH also markets an oral formulation. What should the PSUR assessment do first?

Apply the concern automatically to all formulations because they contain the same active substance Exclude the concern from the PSUR because it does not involve the most widely used formulation Assess whether the mechanism and evidence are formulation-specific or support a broader product-level risk Replace the formulation-specific reference information with the global core document without further analysis

Question 8 of 10 Which statement best describes the relationship between changes to the RMP and changes to reference safety information?

Every RMP change automatically requires a product-information change Every product-information change automatically requires an RMP change They may be related but are not synonymous; evidence and regulatory decisions determine what changes occur Neither type of change needs to be considered in a PSUR

Question 9 of 10 A single PSUR covers products with different routes and indications. What is the principal analytical risk if the evidence is combined without qualification?

The PSUR will contain too many references Clinically distinct exposures and risks may be obscured by an undifferentiated product-level analysis International safety information will automatically become invalid The DLP will no longer apply to any product

Question 10 of 10 Why is a global safety database not, by itself, the regulatory reference for an EU PSUR?

Because global databases cannot contain individual case safety reports Because the database must be placed within defined product scope, indications, formulations, data cut-off and reference information Because international data are prohibited from being used in EU periodic reports Because only data from the EU database can be used for benefit-risk assessment

QPPV.com

Knowledge Assessment: GVP Module VII — PSUR Reference Data and International Safety Information

Cookie Settings